But a new program offered by Mercy Springfield is reducing the time patients are spending in the hospital. Last September, ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

Intensifying oral diuretic therapy was linked to worse prognosis, but not everybody is sold on its use an endpoint.

Eko Health, a leader in artificial intelligence (AI) for the early detection of heart and lung diseases, today announced the ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

LeerinkGlobal Biopharma Conference: Robert I. Blum, President and Chief Executive Officer, and Andrew Callos, Executive Vice President and Chief Commercial Officer, will participate in a fireside chat ...

The initial clinical assessments elicited stark awareness of a syndromic condition of varied causes (originally rheumatic heart disease, hypertension, and coronary disease) characterized by abysmal ...

Pulnovo Medical has closed a Series C financing round, securing around $100m for progressing the company's worldwide trials, ...

Pulnovo Medical, a developer of medical devices for pulmonary hypertension and heart failure, has closed its oversubscribed Series C funding round at nearly $100 million to advance global clinical ...

The new Aala medical respite shelter on North King Street has taken in and treated some of Oahu’s oldest and most seriously ...

Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This ...

Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...